Bicycle Therapeutics (BCYC) Other Working Capital Changes (2018 - 2026)

Bicycle Therapeutics' Other Working Capital Changes history runs 9 years deep, the most recent figure standing at -$1.3 million for Q1 2026.

• Quarterly Other Working Capital Changes rose 0.93% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (up 12.78% YoY) and the FY2025 annual result came in at -$5.5 million, down 11.62% from the prior year.
• Other Working Capital Changes was -$1.3 million for Q1 2026 at Bicycle Therapeutics, up from -$1.4 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $89.7 million in Q3 2023 and bottomed at -$79.1 million in Q4 2025.
• A 5-year average of -$5.8 million and a median of -$706000.0 in 2026 frame the typical range for Other Working Capital Changes.
• Annual changes were most pronounced in 2023 — Other Working Capital Changes jumped 1266.27% — and 2025, when it sank 2294.92%.
• Bicycle Therapeutics' Other Working Capital Changes stood at -$2.6 million in 2022, then slumped by 73.9% to -$4.6 million in 2023, then dropped by 11.56% to -$5.1 million in 2024, then jumped by 72.23% to -$1.4 million in 2025, then grew by 9.01% to -$1.3 million in 2026.
• Business Quant data shows BCYC's Other Working Capital Changes at -$1.3 million in Q1 2026, -$1.4 million in Q4 2025, and -$1.4 million in Q3 2025.